Iron deficiency, depression, and fatigue in inflammatory bowel diseases

Abstract

Background Iron deficiency and anemia are common findings in IBD. Treatment of anemia improves quality of life. Neurological symptoms like depression or anxiety are also common in IBD; however, their relationship with ID has not been studied in detail.

Methods Prospective, single center, non-interventional trial in an IBD cohort (n = 98), which is generally at risk for ID. Quality of sleep (using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Insomnia Severity Index) and the presence of fatigue (Piper fatigue scale), depression (Self-rating Depression Scale [SDS]) or anxiety (Self-rating Anxiety Scale [SAS]) were related to ID (ferritin, transferrin saturation), anemia (hemoglobin), and inflammatory disease activity (CRP).

Results ID was present in 35 %, anemia in 16 %, and inflammation in 30 %. The overall quality of sleep in this cohort was similar to that reported for the general population. ID, anemia, or inflammation had no influence on the PSQI (median 4.0 [CI 3.0–5.0]), the ESS 5.5 (5.0–7.0), and the ISI 4.00 (2.5–5.5). Fatigue (PFS; present in 30 %), anxiety (SAS; present in 24 %), and depression (SDS; present in 33 %) were more common than in the general population. Iron deficient and anemic patients were more likely to be depressed (p = 0.02 and p < 0.01) and showed a trend towards presence of fatigue (p = 0.06 and 0.07). Systemic inflammation as measured by CRP had no effect on any of these conditions.

Conclusion In this IBD cohort, ID and anemia affect depression and possibly fatigue independent of the presence of inflammation.

Zusammenfassung

Hintergrund Eisenmangel und Anämie sind häufige extraintestinale Komplikationen der chronisch entzündlichen Darmerkrankungen (CED). Eine Behandlung der Anämie verbessert die Lebensqualität. Neurologische Symptome wie Depression oder Angst sind ebenfalls häufig bei CED; deren Zusammenhang mit Eisenmangel wurde aber noch nicht untersucht.

Methoden Prospektive, monozentrische, nichtinterventionelle Studie an Patienten mit CED (n = 98). Schlafqualität (mittels PSQI-Pittsburgh Sleep Quality Index, ESS-Epworth Sleepiness Scale, und ISI-Insomnia Severity Index) und das Vorliegen von Erschöpfung (PFS-Piper fatigue scale), Depression (SDS-Self-rating Depression Scale) oder Angst (SAS-Self-rating Anxiety Scale) und deren Zusammenhang mit Eisenmangel (Ferritin, Transferrinsättigung), Anämie (Hämoglobin) oder Entzündung (CRP) wurden untersucht.

Ergebnisse Eisenmangel war bei 35 % der CED-Patienten vorhanden, Anämie in 16 % und Entzündung in 30 % der Fälle. Die Schlafqualität war gesunden Probanden ähnlich. Ergebnisse der PQSI (median 4,0 [KI 3,0–5,0]), ESS 5,5 (5,0–7,0) und ISI 4,00 (2,5–5,5) wurden nicht durch Eisenmangel, Anämie, oder Entzündung beeinflusst. Erschöpfung (PFS; 30 % Prävalenz), Angst (SAS; 24 % Prävalenz) und Depression (SDS, 33 % Prävalenz) waren häufiger bei CED als in der Allgemeinbevölkerung. IBD-Patienten mit Eisenmangel oder Anämie waren häufiger depressiv (p = 0,02 and p < 0,01) und tendierten häufiger zu Erschöpfung (p = 0,06 and 0,07). Entzündungsaktivität – gemessen an CRP – hatte keinen Einfluss auf die Untersuchungsergebnisse.

Schlussfolgerung In dieser IBD-Kohorte beeinflussen Eisenmangel und Anämie die Depression und möglicherweise die Erschöpfung, unabhängig von vorhandener Entzündung.

Key words

IBD - iron deficiency - anxiety - depression - quality of life - quality of sleep

Schlüsselwörter

CED - Eisenmangel - Angst - Depression - Lebensqualität - Schlafqualität

Publikationsverlauf

Eingereicht: 03. Juni 2020

Angenommen: 30. September 2020

Artikel online veröffentlicht:
08. Dezember 2020

• References

• 1 Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther 2006; 24: 1507-1523 . doi:10.1111/j.1365-2036.2006.03146.x
• 2 Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012; 61: 933-952 . doi:10.1136/gut.2010.214312
• 3 Oustamanolakis P, Koutroubakis IE, Messaritakis I. et al Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23: 262-268 . doi:10.1097/MEG.0b013e328343b885
• 4 Gasche C, Berstad A, Befrits R. et al Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-1553 . doi:10.1002/ibd.20285
• 5 Wurzinger B, Konig P. [Iron deficiency, fatigue and restless-legs-syndrome]. Wiesner medizinische Wochenschrift 2016; 166: 447-452 . doi:10.1007/s10354-016-0497-3
• 6 Gonzalez Alayon C, Pedrajas Crespo C, Pedrosa M. et al Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. Gastroenterologia y hepatologia 2018; 41: 22-29 . doi:10.1016/j.gastrohep.2017.07.011
• 7 Wells CW, Lewis S, Barton JR. et al Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123-130 . doi:10.1097/01.MIB.0000196646.64615.db
• 8 van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010; 32: 131-143 . doi:10.1111/j.1365-2036.2010.04347.x
• 9 Evstatiev R, Marteau P, Iqbal T. et al FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-853.e2 . doi:10.1053/j.gastro.2011.06.005
• 10 Gasché C, Dejaco C, Waldhoer T. et al Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997; 126: 782-787
• 11 Favrat B, Balck K, Breymann C. et al Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study. PloS One 2014; 9: e94217 . doi:10.1371/journal.pone.0094217
• 12 Krayenbuehl PA, Battegay E, Breymann C. et al Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011; 118: 3222-3227 . doi:10.1182/blood-2011-04-346304
• 13 Bruner AB, Joffe A, Duggan AK. et al Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996; 348: 992-996 . doi:10.1016/S0140-6736(96)02341-0
• 14 Verdon F, Burnand B, Stubi CLF. et al Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ (Clinical research ed) 2003; 326: 1124 . doi:10.1136/bmj.326.7399.1124
• 15 Byrne G, Rosenfeld G, Leung Y. et al Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 2017; 2017: 6496727 . doi:10.1155/2017/6496727
• 16 Neuendorf R, Harding A, Stello N. et al Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res 2016; 87: 70-80 . doi:10.1016/j.jpsychores.2016.06.001
• 17 Choi K, Chun J, Han K. et al Risk of anxiety and depression in patients with inflammatory bowel disease: a nationwide, population-based study. J Clin Med 2019; 8
• 18 Bernstein CN. Psychological stress and depression: risk factors for IBD?. Dig Dis 2016; 34: 58-63 . doi:10.1159/000442929
• 19 Gasche C, Scholmerich J, Brynskov J. et al A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15
• 20 Silverberg MS, Satsangi J, Ahmad T. et al Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19: 5A-36A
• 21 WHO. Nutritional anaemias. Report of a WHO scientific group. World Health Organization Technical Report Series 1968; 405: 5-37
• 22 Buysse DJ, Reynolds CF, Monk TH. et al The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
• 23 Riemann D, Backhaus J. [Group therapy approaches in primary/psychophysiologic insomnias]. Wiener medizinische Wochenschrift 1995; 145: 529-532
• 24 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545
• 25 Bloch KE, Schoch OD, Zhang JN. et al German version of the Epworth Sleepiness Scale. Respiration 1999; 66: 440-447 . doi:10.1159/000029408
• 26 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001; 2: 297-307
• 27 Gerber M, Lang C, Lemola S. et al Validation of the German version of the insomnia severity index in adolescents, young adults and adult workers: results from three cross-sectional studies. BMC Psychiatry 2016; 16: 174 . doi:10.1186/s12888-016-0876-8
• 28 Piper BF. Piper fatigue scale available for clinical testing. Oncol Nurs Forum 1990; 17: 661-662
• 29 Radbruch L, Sabatowski R, Elsner F. et al Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage 2003; 25: 449-458 . doi:10.1016/s0885-3924(03)00073-3
• 30 Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379 . doi:10.1016/S0033-3182(71)71479-0
• 31 Hinz A, Glaesmer H, Brahler E. et al Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med 2017; 30: 57-63 . doi:10.1016/j.sleep.2016.03.008
• 32 Zeitlhofer J, Schmeiser-Rieder A, Tribl G. et al Sleep and quality of life in the Austrian population. Acta Neurol Scand 2000; 102: 249-257 . doi:10.1034/j.1600-0404.2000.102004249.x
• 33 Sander C, Hegerl U, Wirkner K. et al Normative values of the Epworth Sleepiness Scale (ESS), derived from a large German sample. Sleep Breath 2016; 20: 1337-1345 . doi:10.1007/s11325-016-1363-7
• 34 Kroenke K, Wood DR, Mangelsdorff AD. et al Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. J Am Med Assoc 1988; 260: 929-934
• 35 Bromet E, Andrade LH, Hwang I. et al Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90 . doi:10.1186/1741-7015-9-90
• 36 Häuser W, Janke KH, Klump B. et al Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011; 17: 621-632 . doi:10.1002/ibd.21346
• 37 Lee HS, Chao HH, Huang WT. et al Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: a nationwide database analysis. BMC Psychiatry 2020; 20: 216 . doi:10.1186/s12888-020-02621-0
• 38 Yi S, Nanri A, Poudel-Tandukar K. et al Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees. Psychiatry Research 2011; 189: 368-372 . doi:10.1016/j.psychres.2011.03.009
• 39 Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M. et al The relationship between depression and serum ferritin level. Eur J Clin Nutr 2007; 61: 532-535 . doi:10.1038/sj.ejcn.1602542
• 40 Shafi M, Taufiq F, Mehmood H. et al Relation between depressive disorder and iron deficiency anemia among adults reporting to a secondary healthcare facility: a hospital-based case control study. J Coll Physicians Surg Pak 2018; 28: 456-559 . doi:10.29271/jcpsp.2018.06.456
• 41 Stewart R, Hirani V. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosom Med 2012; 74: 208-213 . doi:10.1097/PSY.0b013e3182414f7d
• 42 Dama M, Van Lieshout RJ, Mattina G. et al Iron deficiency and risk of maternal depression in pregnancy: an observational study. J Obstet Gynaecol Can 2018; 40: 698-703 . doi:10.1016/j.jogc.2017.09.027
• 43 Sheikh M, Hantoushzadeh S, Shariat M. et al The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial. Eur J Nutr 2017; 56: 901-908 . doi:10.1007/s00394-015-1140-6
• 44 Best WR, Becktel JM, Singleton JW. et al Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 1976; 70: 439-444
• 45 Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (Clinical research ed) 1989; 298: 82-86
• 46 Hauser G, Tkalcić M, Stimac D. et al Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll Antropol 2011; 35 (Suppl. 02) 203-207
• 47 Remes O, Brayne C, van der Linde R. et al A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and Behavior 2016; 6: e00497 . doi:10.1002/brb3.497
• 48 Jonefjall B, Simren M, Lasson A. et al Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. United European Gastroenterol J 2018; 6: 148-158 . doi:10.1177/2050640617703868
• 49 Goldenberg BA, Graff LA, Clara I. et al Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease?. Am J Gastroenterol 2013; 108: 1392-1397 . doi:10.1038/ajg.2013.14
• 50 Herrera-deGuise C, Casellas F, Robles V. et al Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Inflamm Bowel Dis 2016; 22: 1450-1455 . doi:10.1097/MIB.0000000000000768
• 51 Meyer-Klaucke W, Winkler H, Schünemann V. et al Mössbauer, electron-paramagnetic-resonance and X-ray-absorption fine-structure studies of the iron environment in recombinant human tyrosine hydroxylase. Eur J Biochem 1996; 241: 432-439
• 52 Kulnigg S, Stoinov S, Simanenkov V. et al A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-1192 . doi:10.1111/j.1572-0241.2007.01744.x
• 53 Preiss JC, Bokemeyer B, Buhr HJ. et al [Updated German clinical practice guideline on “Diagnosis and treatment of Crohn’s disease” 2014]. Z Gastroenterol 2014; 52: 1431-1484 . doi:10.1055/s-0034-1385199
• 54 van Leeuwen P, Dignass A, Kucharzik T. et al Z Gastroenterol 2019; 57: e397-e402 . doi:10.1055/a-1015-7324
• 55 Hou JK, Gasche C, Drazin NZ. et al Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2017; 23: 35-43 . doi:10.1097/MIB.0000000000000953
• 56 Lewis K, Marrie RA, Bernstein CN. et al The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis 2019; 25: 1674-1680 . doi:10.1093/ibd/izz045